Backing the future of IoT security with Device Authority

Tern plc

As billions of connected devices flood global markets, the challenge of securing the Internet of Things becomes not just technical, but existential. Device Authority is positioning itself at the heart of this battleground, offering automated, AI-powered protection precisely when traditional security is faltering. This article explores why investors should pay close attention to this rising star in IoT security innovation.

The global Internet of Things (IoT) market is undergoing explosive expansion, projected to skyrocket from 12 billion connected devices in 2020 to over 75 billion by 2030. While this surge fuels economic opportunity across virtually every sector, it also introduces a rapidly growing attack surface. Unprotected endpoints and outdated manual defences have created a fragile landscape, and cyber threats are escalating in both frequency and sophistication.

One of the starkest reminders of this vulnerability was the 2020 cyberattack on a water treatment plant in Florida. Hackers, exploiting poorly secured IoT systems, infiltrated critical infrastructure and manipulated chemical levels in the water supply, threatening public health on a potentially devastating scale. This incident exposed how IoT systems, when left unprotected, can become weapons in the hands of cyber adversaries.

Today, the challenge is becoming even more formidable. AI-powered attacks are now outpacing human-led defence systems, exploiting vulnerabilities in real time with unmatched precision and speed. According to a recent NIST whitepaper, Toward Automating IoT Security, there is an urgent imperative for automation in security protocols. Manual security methods are no longer viable in the face of such high-volume, high-speed threats.

The traditional IT-centric approach, characterised by static, reactive, and human-driven controls—has proven incapable of protecting sprawling, dynamic, and diverse IoT environments. These ecosystems demand scalable, intelligent, and autonomous security mechanisms. Without automation, organisations are increasingly exposed to data breaches, operational disruptions, and unauthorised access, especially across critical sectors such as healthcare, transportation, industrial manufacturing, and utilities.

Device Authority’s KeyScaler platform directly addresses this pressing need. It is an advanced solution purpose-built to provide end-to-end identity lifecycle management for IoT devices. From initial secure onboarding to ongoing machine identity maintenance and policy enforcement, KeyScaler automates security at scale. It eliminates the need for human intervention in core processes, streamlining protection across millions of devices.

KeyScaler enables zero-touch provisioning, allowing devices to be securely onboarded without manual effort. It automates public key infrastructure (PKI) processes, including the issuance, renewal, and revocation of certificates, eliminating the common failure points associated with certificate-based authentication. By applying policy-based identity lifecycle management, KeyScaler ensures that even unmanaged edge devices are governed under robust security protocols.

Crucially, the platform supports encrypted data storage and secure over-the-air updates, enabling organisations to quickly patch vulnerabilities before they are exploited. KeyScaler also integrates AI-powered agents that can respond to threats at machine speed and offer critical insights via Microsoft CoPilot. These features position KeyScaler not just as a tool for compliance, but as a proactive defence mechanism in the fight against next-generation cyberattacks.

Recognised by leaders in the tech ecosystem, Device Authority is already trusted by major players including Microsoft and CyberArk. These partnerships reinforce the company’s credibility and signify a shared vision for a secure IoT future. Their collaboration brings scalable identity management and AI-driven automation to the forefront of enterprise security strategies.

For investors, the company’s presence at high-profile events like the RSA Conference in San Francisco offers an opportunity to witness its technology in action and connect with its leadership team. Those interested in testing the platform firsthand can access a free trial of KeyScaler as a Service (KSaaS), now available via the Azure Marketplace. With growing demand for secure, automated identity solutions in critical infrastructure and enterprise deployments, Device Authority’s offering is both timely and transformative.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern cuts H1 loss by 60% as portfolio growth and funding strengthen

Tern reduced its first-half loss by 60%, with net asset value improving and further fundraising strengthening the balance sheet. Additional funding has supported Talking Medicines and Device Authority, while continued progress across the portfolio provides further scope for value creation.

AI control of machines creates a new market for device trust

AI is beginning to control physical machines, increasing demand for technology that can verify device identity before those machines are allowed to act.

Peptide drug development expands beyond GLP-1

GLP-1 success is widening interest in peptide drug development, with the next phase focused on proving clinical value across new therapeutic areas.

Tern Plc announces 90% take-up of Open Offer

Tern Plc has received valid acceptances for 50.9 million Open Offer Shares, representing approximately 90% of the shares available. The fully underwritten offer will raise approximately £509,368 before expenses, with admission of the new shares expected on 24 September 2026.

Talking Medicines moves to capture pharma demand for better patient intelligence

Tighter US pharma advertising rules could increase demand for patient intelligence, supporting the relevance of Talking Medicines’ DrugVoice platform.

Tern portfolio company Talking Medicines launches ‘Intent to Prescribe’ DrugVoice application

Talking Medicines has launched a new DrugVoice application combining its Message Resonance Score™ with near-real-time point-of-care data to help pharmaceutical companies assess links between HCP message alignment and prescribing intent.

Search